Cognitive Preservation
Herbal Traditions and Global Dementia Patterns

Summary

Dementia develops through a long preclinical phase marked by early structural failures inside neurons, especially within the microtubule cytoskeleton. Microtubules support axonal transport, mitochondrial positioning, and synaptic stability, and their disruption initiates a cascade of dysfunction long before clinical symptoms appear. Central to this collapse is tau hyperphosphorylation, which weakens tau’s ability to stabilise microtubules and promotes its misfolding into neurofibrillary tangles. As microtubules fragment, axonal transport falters, mitochondria become stranded, oxidative stress rises, calcium regulation deteriorates, and synapses lose functional integrity. These interconnected processes form the biological foundation of early neurodegenerative vulnerability.

Global epidemiological data reveal that dementia incidence varies sharply across countries, even after adjusting for age and socioeconomic factors. Regions such as India, Nigeria, Ghana, Peru, Sri Lanka, Japan, and Thailand consistently show lower‑than‑expected incidence, while Western and Northern European nations, along with North America and Australia, show higher rates. One of the most consistent differences between low‑incidence and high‑incidence regions is cultural dietary continuity. Many low‑incidence populations maintain long‑standing diets rich in polyphenols, flavonoids, terpenoids, and other plant‑derived compounds known to influence oxidative stress, mitochondrial resilience, and cytoskeletal stability in laboratory studies.

These patterns suggest an interpretive framework in which early cellular mechanisms, global incidence variation, and cultural dietary traditions intersect. While dietary compounds are not medical treatments and cannot prevent dementia, sustained exposure to phytochemicals that modulate oxidative and cytoskeletal pathways may contribute to population‑level differences in vulnerability. This perspective supports the development of a culturally informed botanical formulation, conceived not as a therapeutic product but as a structured reflection of traditional dietary diversity, aligned with regulatory principles of identity, composition, and safety.

Introduction: Early Microtubular Disruption in Dementia

Dementia begins long before clinical symptoms appear, unfolding through a prolonged preclinical phase in which subtle cellular disturbances accumulate gradually. The earliest detectable abnormalities arise within the neuronal cytoskeleton, particularly the microtubule network that maintains neuronal architecture, supports axonal transport, and stabilises synaptic connections. Microtubules form the structural backbone of axons and dendrites, enabling the movement of mitochondria, vesicles, trophic factors, and membrane components across vast neuronal distances (Weingarten et al. 1975; Cleveland et al. 1977). Because neurons rely on uninterrupted transport to sustain synaptic function, even minor disruptions in microtubule integrity can initiate a cascade of dysfunction that precedes overt neurodegeneration.

Tau, the microtubule‑associated protein responsible for regulating microtubule spacing and rigidity, plays a central role in maintaining cytoskeletal stability. Under normal conditions, tau undergoes controlled phosphorylation that modulates microtubule dynamics. In dementia, however, tau becomes excessively phosphorylated by kinases such as GSK‑3β, CDK5, MAPK, and casein kinase 1, reducing its affinity for microtubules and promoting misfolding (Grundke‑Iqbal et al. 1986; Hanger et al. 2009). Hyperphosphorylated tau detaches from microtubules, leaving them vulnerable to fragmentation. Detached tau becomes more soluble and exposes hydrophobic motifs that accelerate self‑assembly into pathological aggregates. These aggregates evolve into paired helical filaments and ultimately neurofibrillary tangles, which correlate strongly with cognitive decline and disease severity (Braak & Braak 1991; Arriagada et al. 1992).

Microtubule fragmentation disrupts axonal transport, causing mitochondria to accumulate in the soma and depriving synaptic terminals of metabolic support. Vesicle cycling becomes erratic, trophic signalling weakens, and synaptic transmission deteriorates (Stokin et al. 2005; De Vos et al. 2008). Imaging studies show that transport deficits appear before amyloid deposition, indicating that microtubule instability is one of the earliest functional impairments in preclinical Alzheimer’s disease (Gilley et al. 2022). As transport falters, oxidative stress increases. Mitochondria stranded away from synapses generate excess reactive oxygen species (ROS), which oxidise tubulin, destabilise microtubules further, and promote additional tau hyperphosphorylation (Castellani et al. 2006). This creates a self‑reinforcing cycle in which cytoskeletal collapse amplifies oxidative burden, and oxidative burden accelerates cytoskeletal collapse.

Mitochondrial dysfunction deepens this cycle. Fragmented mitochondria produce less ATP, impairing the energy‑dependent processes required for microtubule polymerisation and motor protein function (Reddy & Beal 2008). Early mitochondrial fragmentation and impaired mitophagy have been identified as key features of Alzheimer’s pathology, further weakening cytoskeletal resilience (Fang et al. 2022). Calcium dysregulation compounds these effects. Mitochondria that fail to reach synaptic terminals cannot buffer calcium effectively, leading to elevated intracellular calcium levels. This activates calpain proteases, which cleave tau into aggregation‑prone fragments and destabilise additional cytoskeletal components (Sengupta et al. 2006). Calcium imbalance also disrupts NMDA receptor trafficking, reduces dendritic spine stability, and impairs synaptic vesicle cycling (Busche & Hyman 2020).

As microtubules collapse, neurons lose structural integrity. Axons retract, dendritic spines degenerate, and synaptic density decreases. Long‑range connectivity deteriorates as microtubule‑dependent signalling pathways fail, impairing memory formation, consolidation, and retrieval (Hoover et al. 2010). Connectome studies confirm that microtubule‑related tau pathology predicts large‑scale network breakdown in Alzheimer’s disease (Franzmeier et al. 2023). These early cytoskeletal events form the biological foundation for understanding how neuronal networks lose coherence over time and provide essential context for interpreting global incidence patterns and cultural dietary correlations.

Global Dementia Incidence

Dementia incidence varies dramatically across global regions, reflecting the interplay of demographic structure, cardiovascular and metabolic health, environmental exposures, educational attainment, and cultural dietary continuity. Large‑scale epidemiological analyses from Alzheimer’s Disease International, the WHO Global Dementia Observatory, and the Lancet Commission consistently show that dementia is not evenly distributed worldwide. Instead, distinct geographic patterns emerge in which incidence diverges markedly from predicted values based on age distribution and socioeconomic indicators (Alzheimer’s Disease International 2023; WHO Global Dementia Observatory 2024; Livingston et al. 2020).

Countries with lower‑than‑expected incidence (Table 1) often maintain traditional diets rich in polyphenols, flavonoids, and plant‑derived compounds that modulate oxidative stress and cellular stability (Scarmeas et al. 2009; Lourida et al. 2013). These regions frequently exhibit lower metabolic stress, reduced cardiovascular burden, and cultural dietary continuity. Conversely, countries with higher‑than‑expected incidence (Table 2) tend to show elevated rates of metabolic syndrome, cardiovascular disease, sedentary lifestyle patterns, and environmental factors associated with oxidative load (Prince et al. 2015; Nichols et al. 2022).

Table 1: Countries with Low Dementia Incidence

Table 2: Countries with High Dementia Incidence

These epidemiological patterns suggest that population‑level factors beyond age and socioeconomic status influence vulnerability to early cytoskeletal instability. Cultural dietary continuity emerges as one of the most consistent correlates of lower dementia incidence, providing a plausible context for exploring how long‑standing dietary traditions may intersect with cellular pathways relevant to neurodegenerative vulnerability.

Cultural Dietary Continuity in Low‑Incidence Regions

Across global regions, populations with lower‑than‑expected dementia incidence frequently share long‑standing dietary traditions centred on sustained consumption of plant‑derived compounds with biochemical effects relevant to oxidative stress, inflammation, mitochondrial function, and cytoskeletal stability. Countries such as India, Nigeria, Ghana, Peru, Sri Lanka, and Thailand maintain traditional diets rich in polyphenols, flavonoids, terpenoids, and other phytochemicals shown in laboratory settings to influence microtubule dynamics, tau aggregation, mitochondrial resilience, and oxidative balance (Scarmeas et al. 2009; Lourida et al. 2013; Vauzour et al. 2015).

In South Asia, turmeric, ginger, cinnamon, and galangal form the foundation of daily cooking practices. Curcumin, the primary bioactive compound in turmeric, modulates tau phosphorylation, reduces oxidative stress, and interacts with microtubule proteins under experimental conditions (Yang et al. 2005; Mishra & Palanivelu 2008). Cinnamon polyphenols exhibit antioxidant and anti‑inflammatory properties that may indirectly support cytoskeletal stability (Ranasinghe et al. 2013). Ginger and galangal contain flavonoids and diarylheptanoids that influence cellular signalling pathways associated with stress responses and cytoskeletal regulation (Semwal et al. 2021).

In West Africa, traditional diets incorporate bitter herbs, moringa leaves, hibiscus calyces, and kola nut. Moringa oleifera provides quercetin, kaempferol, and other polyphenols with strong antioxidant properties that modulate cellular stress pathways (Anwar et al. 2007). Hibiscus anthocyanins reduce oxidative damage and influence cytoskeletal stability under stress conditions (Da‑Costa‑Rocha et al. 2014). Bitter leaf (Vernonia amygdalina) contains sesquiterpene lactones and flavonoids that support metabolic regulation and reduce inflammatory signalling.

In the Andean regions of Peru, maca root (Lepidium meyenii) is a staple food traditionally associated with energy balance and resilience under high‑altitude stress. Maca alkaloids and macamides modulate mitochondrial activity, support cellular energy metabolism, and influence stress‑response pathways relevant to cytoskeletal stability (Gonzales et al. 2014).

Japan presents a distinct pattern centred on green tea catechins, particularly epigallocatechin gallate (EGCG). EGCG reduces oxidative stress, modulates tau aggregation, and influences cytoskeletal signalling pathways (Mandel et al. 2011; Li et al. 2021). Marine plants such as kelp and wakame contribute additional polyphenols and minerals that support metabolic stability.

Table 3: Overview of Key Herbal Ingredients Used in Countries with Low Dementia Incidence

Across these diverse regions, three shared features emerge:

  • Sustained intake of polyphenols and flavonoids that reduce oxidative stress, a major contributor to microtubule destabilisation and tau pathology.
  • Modulation of cellular signalling pathways associated with cytoskeletal regulation, including kinases involved in tau phosphorylation.
  • Long‑term cultural reinforcement, creating exposure patterns that differ markedly from Western dietary profiles characterised by higher metabolic stress and lower polyphenol intake.

These observations highlight a consistent intersection between cultural anthropology, cellular neurobiology, and global epidemiology.

Integrated Interpretation and Conceptual Framework

A unified perspective emerges when cellular mechanisms, global incidence variation, and cultural dietary continuity are considered together. Early neurodegenerative processes arise from microtubular disruption driven by tau hyperphosphorylation, oxidative stress, mitochondrial dysfunction, and synaptic collapse. Regions with long‑standing dietary traditions rich in diverse phytochemicals consistently show lower‑than‑expected dementia incidence, suggesting that sustained exposure to compounds influencing oxidative stress and cytoskeletal resilience may contribute to population‑level differences in vulnerability.

This integrated perspective also provides the conceptual foundation for a culturally informed botanical formulation inspired by the phytochemical diversity characteristic of low‑incidence regions. Such a formulation is not a medical intervention and does not imply preventive or therapeutic function. Instead, it represents a structured botanical model reflecting traditional dietary patterns, framed in alignment with EFSA and FDA principles of ingredient identity, composition, and safety (see Annex below).

Within this unified interpretive structure, the formulation becomes a culturally informed botanical concept that translates cross‑regional dietary continuity into a structured nutritional framework. It highlights how diverse phytochemicals found in long‑standing cultural diets intersect with cellular pathways implicated in oxidative stress and cytoskeletal instability, without implying preventive or medical function.

Annex: Regulatory‑Aligned Botanical Identity and Composition

Botanical Ingredient Identity (European Food Safety Authority)

Each botanical is defined according to EFSA’s principles of identity, origin, part used, and traditional context. This establishes the ingredient as a culturally grounded dietary component rather than a therapeutic agent.

Turmeric (Curcuma longa L.)

A rhizome‑derived culinary spice traditionally used in South Asian cuisine. The identity is defined by the dried, ground rhizome containing naturally occurring curcuminoids, primarily curcumin, demethoxycurcumin, and bisdemethoxycurcumin. Traditional use reflects long‑term dietary inclusion rather than medicinal application.

Ginger (Zingiber officinale Roscoe)

A rhizome used globally as a culinary and aromatic ingredient. Identity is established through its characteristic volatile oils and non‑volatile diarylheptanoids. The part used is the fresh or dried rhizome, consumed in food preparations across Asia and Africa.

Cinnamon (Cinnamomum verum J. Presl / C. cassia)

A bark‑derived spice defined by cinnamaldehyde, eugenol, and procyanidins. EFSA identity is based on species, geographic origin, and the dried inner bark used in traditional cooking practices.

Moringa (Moringa oleifera Lam.)

Leaves consumed as vegetables or dried powders in West African and South Asian diets. Identity is defined by the leaf material containing quercetin, kaempferol, and related flavonoids. Traditional use is dietary, not therapeutic.

Hibiscus (Hibiscus sabdariffa L.)

Calyces used for beverages and infusions. Identity is established through anthocyanins (delphinidin‑3‑sambubioside, cyanidin‑3‑sambubioside) and organic acids. EFSA recognises the dried calyx as the part used.

Maca (Lepidium meyenii Walp.)

A root vegetable consumed in Andean regions. Identity is defined by the dried hypocotyl containing macamides, macaenes, and glucosinolates. Traditional use is nutritional and cultural.

Green Tea (Camellia sinensis L.)

Leaves used for infusion. Identity is defined by catechin profiles, especially EGCG, EGC, and ECG. EFSA recognises the dried leaf as the part used.

Galangal (Alpinia galanga Willd.)

A rhizome used in Southeast Asian cuisine. Identity is based on flavonoids and diarylheptanoids naturally present in the dried or fresh rhizome.

This identity‑based framing aligns with EFSA’s botanical guidance by emphasising species, plant part, traditional use, and naturally occurring phytochemical families.

Botanical Composition Description (Food and Drug Administration, United States)

FDA botanical composition language focuses on naturally occurring constituents, non‑standardised profiles, and absence of therapeutic claims. The following description reflects that approach.

The botanical blend consists of whole‑plant materials and minimally processed ingredients traditionally consumed as part of regional diets. Each component contains characteristic phytochemical families that contribute to its natural composition:

  • Curcuminoids (from turmeric): curcumin, demethoxycurcumin, bisdemethoxycurcumin
  • Catechins (from green tea): EGCG, EGC, ECG
  • Flavonoids (from moringa, hibiscus, galangal): quercetin, kaempferol, anthocyanins, chalcones
  • Diarylheptanoids and gingerols (from ginger and galangal)
  • Procyanidins and cinnamaldehyde (from cinnamon)
  • Macamides and glucosinolates (from maca)

These constituents occur naturally in the plant materials and are not isolated, concentrated, or standardised for pharmacological effect. The composition reflects traditional dietary exposure rather than therapeutic dosing. No claims of disease prevention, mitigation, or treatment are associated with these ingredients.

The blend is framed as a culturally informed botanical model, consistent with FDA botanical guidance, emphasising:

  • whole‑plant identity
  • naturally occurring chemical families
  • traditional dietary use
  • non‑therapeutic positioning
  • absence of structure‑function or health claims

This combined EFSA/FDA section provides a regulatory‑aligned foundation for describing botanicals within a conceptual framework that reflects traditional dietary patterns and phytochemical diversity.

References

  • Alzheimer’s Disease International. (2023). World Alzheimer Report 2023.
  • Anwar, F., Latif, S., Ashraf, M., & Gilani, A. H. (2007). Moringa oleifera: A food plant with multiple medicinal uses. Phytotherapy Research, 21(1), 17–25.
  • Arriagada, P. V., Growdon, J. H., Hedley-Whyte, E. T., & Hyman, B. T. (1992). Neurofibrillary tangles but not senile plaques parallel duration and severity of Alzheimer’s disease. Neurology, 42(3), 631–639.
  • Braak, H., & Braak, E. (1991). Neuropathological stageing of Alzheimer-related changes. Acta Neuropathologica, 82(4), 239–259.
  • Busche, M. A., & Hyman, B. T. (2020). Synergy between amyloid-β and tau in Alzheimer’s disease. Nature Neuroscience, 23, 1183–1193.
  • Castellani, R. J., Rolston, R. K., & Smith, M. A. (2006). Alzheimer disease. Disease-a-Month, 52(8), 545–573.
  • Clavaguera, F., Bolmont, T., Crowther, R. A., et al. (2009). Transmission and spreading of tauopathy in transgenic mouse brain. Nature Cell Biology, 11, 909–913.
  • Cleveland, D. W., Hwo, S. Y., & Kirschner, M. W. (1977). Purification of tau protein and its role in microtubule assembly. Journal of Molecular Biology, 116(2), 207–225.
  • Da‑Costa‑Rocha, I., Bonnlaender, B., Sievers, H., Pischel, I., & Heinrich, M. (2014). Hibiscus sabdariffa L.–A phytochemical and pharmacological review. Food Chemistry, 165, 424–443.
  • De Vos, K. J., Grierson, A. J., Ackerley, S., & Miller, C. C. (2008). Role of axonal transport in neurodegenerative diseases. Annual Review of Neuroscience, 31, 151–173.
  • Fang, E. F., Hou, Y., Palikaras, K., et al. (2022). Mitophagy and Alzheimer’s disease: Cellular and molecular mechanisms. Trends in Neurosciences, 45(1), 1–15.
  • Franzmeier, N., Neitzel, J., Rubinski, A., et al. (2023). Functional brain network architecture predicts progression of tau pathology. Nature Communications, 14, 1123.
  • Gilley, J., Adalbert, R., & Coleman, M. P. (2022). Axonal transport failure precedes structural degeneration in Alzheimer’s disease models. Brain, 145(3), 1032–1048.
  • Gonzales, G. F., Villaorduña, L., Gasco, M., et al. (2014). Maca (Lepidium meyenii) and its effects on mitochondrial function and energy metabolism. Evidence-Based Complementary and Alternative Medicine, 2014, 1–10.
  • Grundke‑Iqbal, I., Iqbal, K., Quinlan, M., et al. (1986). Microtubule-associated protein tau: A component of Alzheimer paired helical filaments. Journal of Biological Chemistry, 261(13), 6084–6089.
  • Hanger, D. P., Anderton, B. H., & Noble, W. (2009). Tau phosphorylation: The therapeutic challenge for neurodegenerative disease. Trends in Molecular Medicine, 15(3), 112–119.
  • Hoover, B. R., Reed, M. N., Su, J., et al. (2010). Tau mislocalization to dendritic spines mediates synaptic dysfunction independently of neurodegeneration. Neuron, 68(6), 1067–1081.
  • Li, S., Wu, Y., Chen, X., et al. (2021). EGCG modulates tau aggregation and oxidative stress pathways. Journal of Nutritional Biochemistry, 89, 108–118.
  • Livingston, G., et al. (2020). Dementia prevention, intervention, and care: 2020 report of the Lancet Commission. The Lancet, 396(10248), 413–446.
  • Lourida, I., Soni, M., Thompson-Coon, J., et al. (2013). Mediterranean diet and cognitive function: Systematic review. Epidemiology, 24(4), 479–489.
  • Mandel, S. A., Amit, T., Reznichenko, L., et al. (2011). Green tea catechins as modulators of neurodegeneration. Journal of Nutritional Biochemistry, 22(10), 951–961.
  • Mishra, S., & Palanivelu, K. (2008). The effect of curcumin on Alzheimer’s disease: An overview. Annals of Indian Academy of Neurology, 11(1), 13–19.
  • Nichols, E., et al. (2022). Global, regional, and national burden of Alzheimer’s disease and other dementias, 1990–2019. The Lancet Neurology, 21(5), 413–426.
  • Prince, M., et al. (2015). World Alzheimer Report 2015: The Global Impact of Dementia. Alzheimer’s Disease International.
  • Ranasinghe, P., Pigera, S., Premakumara, G. A., et al. (2013). Cinnamon: A multifaceted medicinal plant. Evidence-Based Complementary and Alternative Medicine, 2013, 1–10.
  • Reddy, P. H., & Beal, M. F. (2008). Amyloid beta, mitochondrial dysfunction and synaptic damage: Implications for Alzheimer’s disease. Current Alzheimer Research, 5(1), 5–13.
  • Scarmeas, N., Stern, Y., Tang, M. X., et al. (2009). Mediterranean diet and Alzheimer disease mortality. Neurology, 69(11), 1084–1093.
  • Semwal, R. B., Semwal, D. K., Combrinck, S., & Viljoen, A. (2021). Gingerols and shogaols: Chemistry, pharmacology and biological activities. Molecules, 26(14), 4098.
  • Sengupta, A., Kabat, J., Novak, M., et al. (2006). Calpain cleavage of tau produces fragments that aggregate. Journal of Biological Chemistry, 281(46), 34302–34309.
  • Stokin, G. B., Lillo, C., Falzone, T. L., et al. (2005). Axonopathy and transport deficits early in Alzheimer’s disease. Science, 307(5713), 1282–1288.
  • Vauzour, D., Vafeiadou, K., Rodriguez-Mateos, A., et al. (2015). Polyphenols and human health: Prevention of disease and mechanisms of action. Nutrients, 7(6), 517–520.
  • Weingarten, M. D., Lockwood, A. H., Hwo, S. Y., & Kirschner, M. W. (1975). A protein factor essential for microtubule assembly. Proceedings of the National Academy of Sciences, 72(5), 1858–1862.
  • WHO Global Dementia Observatory. (2024). Global Dementia Data Portal. World Health Organization.
  • Yang, F., Lim, G. P., Begum, A. N., et al. (2005). Curcumin inhibits formation of amyloid β oligomers and fibrils. Journal of Biological Chemistry, 280(7), 5892–5901.

If you’re interested in this concept, please contact me to discuss.

Licence: All ideas and concepts shown on this website are shared under the Creative Commons Attribution 4.0 International Licence (CC BY 4.0) . You are free to use, adapt, and build upon them, provided you give appropriate credit to Dr. Patrick Reynolds and include a link to this website.
© 2026 Patrick Reynolds